Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Tanda ML
  • Piantanida E
  • Bartalena L
  • MESH
  • Adipocytes, White
  • Adipogenesis
  • Animals
  • Antithyroid Agents
  • Down-Regulation
  • Female
  • Graves Ophthalmopathy
  • Humans
  • Immunosuppressive Agents
  • Iodine Radioisotopes
  • Male
  • Radiopharmaceuticals
  • Thalidomide
  • Thyroidectomy

Unbound MEDLINE

Treating Graves' orbitopathy: where are we?

Links

  • Publisher Full Text
  • Authors

    Tanda ML, Piantanida E, Bartalena L

    Source

    Endocrine 41:2 2012 Apr pg 167-8

    MeSH

    Adipocytes, White
    Adipogenesis
    Animals
    Antithyroid Agents
    Down-Regulation
    Female
    Graves Ophthalmopathy
    Humans
    Immunosuppressive Agents
    Iodine Radioisotopes
    Male
    Radiopharmaceuticals
    Thalidomide
    Thyroidectomy

    Pub Type(s)

    Comment
    Editorial

    Language

    eng

    PubMed ID

    22274832

    Related Citations

    • Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
    • Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.
    • The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    • A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    • [Graves' ophthalmopathy].
    • Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
    • [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    • Treating the thyroid in the presence of Graves' ophthalmopathy.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved